Advanced Materials,
Journal Year:
2021,
Volume and Issue:
34(11)
Published: Dec. 29, 2021
The
immunosuppressive
tumor
microenvironment
(TME)
always
causes
poor
antitumor
immune
efficacy,
prone
to
relapse
and
metastasis.
Herein,
novel
poly(vinylpyrrolidone)
(PVP)
modified
BiFeO3
/Bi2
WO6
(BFO/BWO)
with
a
p-n
type
heterojunction
is
constructed
for
reshaping
the
TME.
Reactive
oxygen
species
can
be
generated
under
light
activation
by
well-separated
hole
(h+
)-electron
(e-
)
pairs
owing
in
BFO/BWO-PVP
NPs.
Interestingly,
h+
trigger
decomposition
of
H2
O2
generate
alleviating
hypoxia,
which
not
only
sensitizes
photodynamic
therapy
(PDT)
radiotherapy
(RT),
but
also
promotes
tumor-associated
macrophages
(TAMs)
polarization
from
M2
M1
phenotype,
beneficial
decrease
expression
HIF-1α.
Importantly,
such
light-activated
nanoplatform,
combining
RT
efficiently
activate
recruit
cytotoxic
T
lymphocytes
infiltrate
tissues,
as
well
stimulate
TAMs
dramatically
reverse
TME
into
an
immunoactive
one,
further
boost
memory
responses.
Moreover,
NPs
present
high
performance
computed
tomography
imaging
contrast.
Taken
together,
this
work
offers
paradigm
achieving
self-supply
inorganic
nanoagents
effective
inhibition
cancer
metastasis
recurrence.
Aggregate,
Journal Year:
2024,
Volume and Issue:
5(3)
Published: Feb. 1, 2024
Abstract
Phototherapeutic
nanoplatforms
that
combine
photodynamic
therapy
(PDT)
and
photothermal
(PTT)
with
the
guidance
of
photoacoustic
(PA)
imaging
are
an
effective
strategy
for
treatment
tumors,
but
establishing
a
universal
method
this
has
been
challenging.
In
study,
we
present
supramolecular
assembly
based
on
Förster
resonance
energy
transfer
to
construct
nanostructured
phototherapeutic
agent
(PcDA)
via
anion
cation
interaction
between
two
water‐soluble
phthalocyanine
ramifications,
PcD
PcA.
This
approach
promotes
absorption
energy,
thus
enhancing
generation
reactive
oxygen
species
(ROS)
heat
by
PcDA,
improving
its
therapeutic
efficacy,
overcoming
low
photon
utilization
efficiency
conventional
PSs.
Notably,
after
intravenous
injection
neoplastic
sites
could
be
clearly
visualized
using
PA
imaging,
signal‐to‐liver
ratio
as
high
11.9.
Due
these
unique
features,
PcDA
exhibits
excellent
antitumor
efficacy
in
preclinical
model
at
dose
light
irradiation.
study
offers
general
development
efficient
agents
simultaneous
effect
PDT
PTT
against
tumors
assistance
imaging.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(37)
Published: April 23, 2024
Abstract
Breast
cancer
stem
cells
(CSCs)
are
responsible
for
the
occurrence,
resistance,
recurrence,
invasion,
and
metastasis
of
tumors.
However,
even
trace
amounts
CSCs
may
lead
to
tumor
resistance
which
fundamentally
reduces
therapeutic
efficiency
numerous
anticancer
drugs.
Thus,
development
a
agent
that
can
reduce
tumorigenicity
overcome
recurrence
is
essential.
Here
novel
multifunctional
prodrug
T‐P
reported
as
photosensitizer,
links
phenothiazine
drug
with
synthesized
aggregation‐induced
emission
photosensitizer
T‐C
via
an
ester
bond.
Importantly,
this
found
be
able
induce
pyroptosis
breast
well
activate
their
death
pathway
protein
phosphatase
2A
inhibit
systemic
anti‐tumor
effects.
rapidly
target
mitochondria
overlap
lysosomes
after
mitochondrial
escape,
it
cause
lysosomal
dysfunction.
It
releases
reactive
oxygen
species
through
photoactivation,
triggering
pyroptosis‐mediated
strong
immune
response.
On
5th
day
in
vivo
therapy
cancer,
primary
eliminated
growth
distant
tumors
also
inhibited.
This
research
would
provide
impetus
new
strategy
CSCs‐targeted
photoimmunotherapy
beyond.
ACS Nano,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 6, 2025
The
treatment
of
pancreatic
cancer
faces
significant
challenges
due
to
connective
tissue
hyperplasia
and
severe
hypoxia.
Unlike
oxygen-dependent
Type
II
photosensitizers,
I
photosensitizers
can
produce
a
substantial
amount
reactive
oxygen
species,
even
under
hypoxic
conditions,
making
them
more
suitable
for
photodynamic
therapy
cancer.
However,
the
dense
extracellular
matrix
limits
penetration
efficiency
presence
immunosuppressive
cells
in
tumor
microenvironment
reduces
therapeutic
effect.
To
address
these
challenges,
we
designed
photoimmunotherapeutic
M1@PAP
nanoparticles
composed
photosensitizer
anti-PD-L1
siRNA
(siPD-L1),
which
was
encapsulated
into
M1
macrophage
membrane
vesicles.
In
this
system,
pyropheophorbide-a
(PPA)
covalently
conjugated
poly-l-arginine
(Arg9).
Notably,
it
capable
generating
sufficient
superoxide
anions
thereby
functioning
as
photosensitizer.
Furthermore,
Arg9
acted
nitric
oxide
(NO)
donor,
enhancing
nanophotosensitizer
by
inhibiting
cancer-associated
fibroblast
(CAF)
activation
decomposing
matrix.
Additionally,
vesicles
provided
active
targeting
capabilities
reeducated
immunosuppressed
M2
macrophages.
reversal
further
promoted
efficacy
immunotherapy,
showing
great
potential
synergistic
immunotherapy
against
tumor.
Advanced Materials,
Journal Year:
2021,
Volume and Issue:
34(11)
Published: Dec. 29, 2021
The
immunosuppressive
tumor
microenvironment
(TME)
always
causes
poor
antitumor
immune
efficacy,
prone
to
relapse
and
metastasis.
Herein,
novel
poly(vinylpyrrolidone)
(PVP)
modified
BiFeO3
/Bi2
WO6
(BFO/BWO)
with
a
p-n
type
heterojunction
is
constructed
for
reshaping
the
TME.
Reactive
oxygen
species
can
be
generated
under
light
activation
by
well-separated
hole
(h+
)-electron
(e-
)
pairs
owing
in
BFO/BWO-PVP
NPs.
Interestingly,
h+
trigger
decomposition
of
H2
O2
generate
alleviating
hypoxia,
which
not
only
sensitizes
photodynamic
therapy
(PDT)
radiotherapy
(RT),
but
also
promotes
tumor-associated
macrophages
(TAMs)
polarization
from
M2
M1
phenotype,
beneficial
decrease
expression
HIF-1α.
Importantly,
such
light-activated
nanoplatform,
combining
RT
efficiently
activate
recruit
cytotoxic
T
lymphocytes
infiltrate
tissues,
as
well
stimulate
TAMs
dramatically
reverse
TME
into
an
immunoactive
one,
further
boost
memory
responses.
Moreover,
NPs
present
high
performance
computed
tomography
imaging
contrast.
Taken
together,
this
work
offers
paradigm
achieving
self-supply
inorganic
nanoagents
effective
inhibition
cancer
metastasis
recurrence.